Literature DB >> 117733

Cricopharyngeus myotomy as the only treatment for Zenker diverticulum.

L Zuckerbraun, M S Bahna.   

Abstract

Cricopharyngeal dysfunction, one of the most common causes of pharyngeal dysphagia, exhibits a variety of manifestations, one of which is Zenker diverticulum. This paper examines the physiology of swallowing, pathophysiology of its aberrations, and various methods of treating Zenker diverticulum. It is our purpose to emphasize cricopharyngeus (CP) myotomy as the only needed treatment for this diverticulum. Even in its advanced stages, excision of the diverticulum is a needless surgical exercise. Seven cases of Zenker diverticulum are reported in elderly patients; one of them had an excision of the diverticulum prior to presentation. Some were either completely obstructed or aspirating on esophagram. Cricopharyngeus myotomy, the only treatment provided, proved to be safe and effective without morbidity or fatalities. Patients' ability to eat orally was restored on the night of or the morning after surgery. No Levin tube is necessary and there is no risk of suture line leakage after the conventional diverticulectomy and CP myotomy. Hospital stay is greatly reduced and there is no risk of structure formation. In contrast to endoscopic division of CP muscle, there is no risk of mediastinitis because there is no break through the mucosa.

Entities:  

Mesh:

Year:  1979        PMID: 117733     DOI: 10.1177/000348947908800610

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  2 in total

1.  A Unusual Case of Complicated Zenker's Diverticulum.

Authors:  P R K Bhargav; C H Venkata Pavan Kumar; A Vinaya Kumar; S D Bhagat; K B Gayathri; V Amar
Journal:  Indian J Surg       Date:  2011-05-21       Impact factor: 0.656

2.  Postoperative pharyngocutaneous fistula: treated by sternocleidomastoid flap repair and cricopharyngeus myotomy.

Authors:  V A Iyoob
Journal:  Eur Spine J       Date:  2012-09-19       Impact factor: 3.134

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.